2100 - Manufacture of basic pharmaceutical product
Net Revenue (M€): 31.0 M€ EBITDA (M€): 3.5 M€
Buyer for a pharmaceutical contract manufacturer
Listed by M&A World Business Support Center on Thursday, 07 December 2017 [Investor (Buy-side)] - Ref.: 854
1416 Hits
Net Revenue (M€): 5.0 M€ EBITDA (M€): 3.0 M€ Number of Employees: 10
With 17 years in the market, and 35 years of R&D, the company is a family enterprise specialized in the development of non allopathic medicine for veterinary use. Possessing its own technology, the medicine is destined to the treatment of the main pathology and the acceleration of animal development for birds, fishes, cattle, horses, swine, sheep, goats and others. The company has a strong presence in the endecto segment.
The company has more than 100 registered patents, composing a complete
Listed by Elit Capital on Friday, 03 March 2017 [Seller (Sell-side)] - Ref.: 19
3803 Hits
Net Revenue (M€): 96.3 M€ EBITDA (M€): 11.0 M€ Number of Employees: 321
The Company is a fast growing company that markets specialty pharmaceuticals around the globe for which there is a high medical need. In addition to drugs for widespread illnesses there is a great need for medications to treat special medical conditions. The Company specializes in these pharmaceuticals for which there is a high unmet medical need.
Listed by M&A World Business Support Center on Wednesday, 01 March 2017 [Investor (Buy-side)] - Ref.: 602
6038 Hits